carvedilol has been researched along with Hypertrophy, Right Ventricular in 1 studies
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tual, L | 1 |
| Morel, OE | 1 |
| Favret, F | 1 |
| Fouillit, M | 1 |
| Guernier, C | 1 |
| Buvry, A | 1 |
| Germain, L | 1 |
| Dhonneur, G | 1 |
| Bernaudin, JF | 1 |
| Richalet, JP | 1 |
1 other study available for carvedilol and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Hypertrop | 2006 |